Free Access
Med Sci (Paris)
Volume 26, Number 6-7, Juin–Juillet 2010
Page(s) 652 - 654
Section Forum
Published online 15 June 2010
  1. Gratwohl A, Baldomero H. Trends of hematopoietic stem cell transplantation in the third millennium. Curr Opin Hematol 2009 ; 16 : 420-6. [Google Scholar]
  2. Gratwohl A, Baldomero H, Frauendorfer K, et al. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products. Bone Marrow Transplant 2008 ; 41 : 687-705. [Google Scholar]
  3. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A. EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant 2006 ; 37 : 1069-85. [Google Scholar]
  4. Gratwohl A, Baldomero H, Frauendorfer K, et al. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007 ; 39 : 71-87. [Google Scholar]
  5. Gratwohl A, Baldomero H, Schwendener A, et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009 ; 43 : 275-91. [Google Scholar]
  6. LeMaistre CF, Loberiza FR Jr. What is quality in a transplant program? Biol Blood Marrow Transplant 2005 ; 11 : 241-6. [Google Scholar]
  7. Lartigau E, Coche-Dequeant B, Dumortier V, et al. Experience feed back committee in radiotherapy (CREx): a compulsory tool for security management evaluation at two years. Cancer Radiother 2008 ; 12 : 610-3. [Google Scholar]
  8. Apperley J. Just another cost increasing exercise (JACIE)? Bone Marrow Transplant 2004 ; 34 : 835-8. [Google Scholar]
  9. Pamphilon D, Apperley JF, Samson D, et al. JACIE Accreditation in 2008: Demonstrating Excellence in Stem Cell Transplantation. Hematol Oncol Stem Cell Ther 2009 ; 2 : 311-9. [Google Scholar]
  10. Gratwohl A, Brand R, Niederwieser D, et al. Impact of JACIE accreditation on outcome after haematopoietic stem cell transplantation: an EBMT megafile registry based analysis. Bone Marrow Transplant 2010 ; 45 : S63 (abstract). [Google Scholar]
  11. Klingebiel T, Cornish J, Labopin M, et al. Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplant in children with very-high risk acute lymphoblastic leukemia. Impact of center size: an analysis on behalf of the acute leukemia and pediatric disease working parties of the European blood and marrow transplant group. Blood 2009 ; 115 : 3437-46. [Google Scholar]
  12. Afolalu B, Troidle L, Osayimwen O, et al. Technique failure and center size in a large cohort of peritoneal dialysis patients in a defined geographic area. Perit Dial Int 2009 ; 29 : 292-6. [Google Scholar]
  13. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986 ; 314 : 729-35. [Google Scholar]
  14. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005 ; 23 : 5074-87. [Google Scholar]
  15. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001 ; 97 : 2962-71. [Google Scholar]
  16. Niederwieser D, Maris M, Shizuru JA, et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003 ; 101 : 1620-9. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.